The CEO of the British-Swedish pharmaceutical company says the EU signed its contract with the firm three months after the UK did, allowing for less time to iron out production problems.
AstraZeneca's delay explanation is inadequate: EU
The European Union health commissioner says that AstraZeneca had provided insufficient clarification at a meeting on Monday on its..
Reuters - Politics